{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:52:20Z","timestamp":1790805140556,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000615","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004033","name":"Johannes Gutenberg University Mainz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014913","name":"Federal State of Saxony","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck and Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001828","name":"Erasmus University Rotterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011377","name":"International Glaucoma Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010327","name":"Stichting Glaucoomfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019535","name":"Texas Technical University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007465","name":"UiT Arctic University of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004346","name":"Rhineland Palatinate Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006022","name":"French Government Ministry of Social Affairs Health and Womens Rights","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007254","name":"Creighton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010374","name":"Stichting Blindenhulp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Nederland Ministerie van Volksgezondheid Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003506","name":"Norwegian Ministry of Health and Care Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004431","name":"European Commission Directorate-General for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010328","name":"Stichting Lijf en Leven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003061","name":"Erasmus Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016994","name":"University Hospital of North Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016994","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010372","name":"Rotterdamse Stichting Blindenbelangen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003245","name":"Nederland Ministerie van Onderwijs Cultuur en Wetenschap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001255","name":"Lister Institute of Preventive Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim International GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"UCLA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010331","name":"Stichting voor Ooglijders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010321","name":"Oogfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ophtha.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T21:18:08Z","timestamp":1683321488000},"page":"893-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Association of Systemic Medication Use with Glaucoma and Intraocular Pressure"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-4302","authenticated-orcid":false,"given":"Jo\u00eblle E.","family":"Vergroesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-8774","authenticated-orcid":false,"given":"Kelsey V.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5680-5527","authenticated-orcid":false,"given":"Nigus G.","family":"Asefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-5764","authenticated-orcid":false,"given":"Audrey","family":"Cougnard-Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-0481","authenticated-orcid":false,"given":"C\u00e9cile","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-6343","authenticated-orcid":false,"given":"Robert N.","family":"Luben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-7753","authenticated-orcid":false,"given":"Julia V.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-4268","authenticated-orcid":false,"given":"Toralf","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-0340","authenticated-orcid":false,"given":"Franziska G.","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wirkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomdo M.","family":"Jansonius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-8818","authenticated-orcid":false,"given":"Louis","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3587-4598","authenticated-orcid":false,"given":"Catherine P.","family":"Creuzot-Garcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno H.","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9028-9607","authenticated-orcid":false,"given":"Christina","family":"Keskini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotis","family":"Topouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5605-4321","authenticated-orcid":false,"given":"Geir","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Eggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-8883","authenticated-orcid":false,"given":"Mukharram M.","family":"Bikbov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5227","authenticated-orcid":false,"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.W.","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-5281","authenticated-orcid":false,"given":"Wishal D.","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6802-8585","authenticated-orcid":false,"given":"Anthony P.","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ophtha.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261897","article-title":"Blindness and visual impairment in Central Europe","volume":"17","author":"Glatz","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40266-012-0036-x","article-title":"Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma","volume":"30","author":"Huber","year":"2013","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ceo.12763","article-title":"Associations between chronic systemic diseases and primary open angle glaucoma: an epidemiological perspective","volume":"45","author":"Tham","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10792-021-02137-w","article-title":"Systemic diseases and their association with open-angle glaucoma in the population of Stockholm","volume":"42","author":"W\u00e4ndell","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1167\/iovs.15-18373","article-title":"Diabetes, triglyceride levels, and other risk factors for glaucoma in the National Health and Nutrition Examination Survey 2005\u20132008","volume":"57","author":"Ko","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41433-019-0603-z","article-title":"A\u00a0review of systemic medications that may modulate the risk of glaucoma","volume":"34","author":"Wu","year":"2020","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.ophtha.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ophtha.2018.01.007","article-title":"Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma","volume":"125","author":"Zheng","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0014-4835(75)90126-8","article-title":"Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers","volume":"21","author":"Wettrell","year":"1975","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.ophtha.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1136\/bjophthalmol-2016-309993","article-title":"Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study","volume":"101","author":"H\u00f6hn","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jamaophthalmol.2016.5318","article-title":"Association of systemic medication use with intraocular pressure in a multiethnic Asian population: the Singapore Epidemiology of Eye Diseases Study","volume":"135","author":"Ho","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.63.5.31","article-title":"Statin use in relation to intraocular pressure, glaucoma, and ocular coherence tomography parameters in the UK Biobank","volume":"63","author":"Kim","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10654-015-0098-2","article-title":"Ophthalmic epidemiology in Europe: the \u201cEuropean Eye Epidemiology\u201d (E3) Consortium","volume":"31","author":"Delcourt","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ophtha.2023.05.001_bib14","article-title":"Anatomical therapeutic chemical\/defined daily dose index","year":"2022","journal-title":"World Health Organization"},{"issue":"12","key":"10.1016\/j.ophtha.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ophtha.2007.03.047","article-title":"Systemic antihypertensive medication and incident open-angle glaucoma","volume":"114","author":"M\u00fcskens","year":"2007","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ophtha.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.61.11.25","article-title":"Autonomic dysfunction and blood pressure in glaucoma patients: the Lifelines Cohort Study","volume":"61","author":"Asefa","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bjo.2004.053397","article-title":"Systemic hypertension and glaucoma: mechanisms in common and co-occurrence","volume":"89","author":"Langman","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ophtha.2020.07.051","article-title":"Association of antihypertensive medication with retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness","volume":"128","author":"Chong","year":"2021","journal-title":"Ophthalmology"},{"issue":"1\u20132","key":"10.1016\/j.ophtha.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/07420528.2012.709448","article-title":"Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation","volume":"30","author":"Hermida","year":"2013","journal-title":"Chronobiol Int"},{"issue":"8","key":"10.1016\/j.ophtha.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3109\/07420528.2010.510230","article-title":"Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study","volume":"27","author":"Hermida","year":"2010","journal-title":"Chronobiol Int"},{"issue":"12","key":"10.1016\/j.ophtha.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1681\/ASN.2011040361","article-title":"Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD","volume":"22","author":"Hermida","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ophtha.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/dc11-0297","article-title":"Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes","volume":"34","author":"Hermida","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ophtha.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/ajh\/hpaa112","article-title":"Daytime or nighttime administration of antihypertensive medications?","volume":"33","author":"Sharma","year":"2020","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.ophtha.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ophtha.2014.04.016","article-title":"Nocturnal systemic hypotension increases the risk of glaucoma progression","volume":"121","author":"Charlson","year":"2014","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0039-6257(99)00016-8","article-title":"Nocturnal hypotension: role in glaucoma progression","volume":"43","author":"Graham","year":"1999","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41598-020-80705-3","article-title":"Nocturnal blood pressure dip and parapapillary choroidal microvasculature dropout in normal-tension glaucoma","volume":"11","author":"Shin","year":"2021","journal-title":"Sci Rep"},{"issue":"26","key":"10.1016\/j.ophtha.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198212233072605","article-title":"Mechanism of action of calcium-channel-blocking agents","volume":"307","author":"Braunwald","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ophtha.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","article-title":"Retinal ischemia: mechanisms of damage and potential therapeutic strategies","volume":"23","author":"Osborne","year":"2004","journal-title":"Prog Retinal Eye Res"},{"issue":"6","key":"10.1016\/j.ophtha.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0361-9230(03)00070-4","article-title":"Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma","volume":"62","author":"Osborne","year":"2004","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","article-title":"Use of calcium channel blockers for glaucoma","volume":"30","author":"Araie","year":"2011","journal-title":"Prog Retinal Eye Res"},{"issue":"14","key":"10.1016\/j.ophtha.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1167\/iovs.19-27984","article-title":"Association of systemic medication exposure with glaucoma progression and glaucoma suspect conversion in the Groningen Longitudinal Glaucoma Study","volume":"60","author":"Pappelis","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1167\/iovs.09-4821","article-title":"Hypotensive medication, statins, and the risk of glaucoma","volume":"51","author":"Owen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.ophtha.2014.02.009","article-title":"Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study","volume":"121","author":"Khawaja","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/jop.2021.0096","article-title":"Effect of blood pressure reduction on intraocular pressure and ophthalmic artery blood flow velocity in hypertension","volume":"38","author":"Behera","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.ophtha.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.3390\/jcm10132947","article-title":"Psychopharmacological treatment, intraocular pressure and the risk of glaucoma: a review of literature","volume":"10","author":"Ciobanu","year":"2021","journal-title":"J Clin Med"},{"issue":"8999","key":"10.1016\/j.ophtha.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(96)90041-0","article-title":"Amaurosis fugax on standing and angle-closure glaucoma with clomipramine","volume":"347","author":"Schlingemann","year":"1996","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ophtha.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5694\/j.1326-5377.1966.tb97299.x","article-title":"Amitriptyline and glaucoma","volume":"2","author":"Lowe","year":"1966","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archopht.1994.01090130077021","article-title":"Oral imipramine and acute angle closure glaucoma","volume":"112","author":"Ritch","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2023.05.001_bib40","article-title":"Effects of selective serotonin reuptake inhibitors on glaucoma: a nationwide population-based study","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15569527.2017.1330270","article-title":"Effects of selective serotonin reuptake inhibitors on intraocular pressure and anterior segment parameters in open angle eyes","volume":"37","author":"G\u00fcnd\u00fcz","year":"2018","journal-title":"Cutan Ocul Toxicol"},{"issue":"45","key":"10.1016\/j.ophtha.2023.05.001_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002041","article-title":"Long-term use of selective serotonin reuptake inhibitors and risk of glaucoma in depression patients","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ophtha.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2018.07.079","article-title":"The risk of glaucoma and serotonergic antidepressants: a systematic review and meta-analysis","volume":"241","author":"Wang","year":"2018","journal-title":"J\u00a0Affect Disord"},{"issue":"8","key":"10.1016\/j.ophtha.2023.05.001_bib44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00023210-200418080-00001","article-title":"SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms","volume":"18","author":"Costagliola","year":"2004","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.ophtha.2023.05.001_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157015908787386104","article-title":"Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure","volume":"6","author":"Costagliola","year":"2008","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"10.1016\/j.ophtha.2023.05.001_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","article-title":"Ocular adverse effects of common psychotropic agents: a review","volume":"24","author":"Richa","year":"2010","journal-title":"CNS Drugs"},{"issue":"Suppl","key":"10.1016\/j.ophtha.2023.05.001_bib47","first-page":"59","article-title":"Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects","volume":"49","author":"Saletu","year":"1988","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12886-018-0811-5","article-title":"The association between glaucoma and risk of depression: a nationwide population-based cohort study","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/IJG.0000000000001830","article-title":"Depression and severity of glaucoma among older adults in urban and suburban areas","volume":"30","author":"Tharmathurai","year":"2021","journal-title":"J\u00a0Glaucoma"},{"issue":"7","key":"10.1016\/j.ophtha.2023.05.001_bib50","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/IJG.0b013e318163bdd1","article-title":"Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15","volume":"17","author":"Skalicky","year":"2008","journal-title":"J\u00a0Glaucoma"},{"issue":"3","key":"10.1016\/j.ophtha.2023.05.001_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1176\/appi.neuropsych.12020030","article-title":"Depression, anxiety, and disturbed sleep in glaucoma","volume":"25","author":"Agorastos Agorastos","year":"2013","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"9","key":"10.1016\/j.ophtha.2023.05.001_bib52","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ophtha.2022.04.023","article-title":"The association between serum lipids and intraocular pressure in 2 large United Kingdom cohorts","volume":"129","author":"Madjedi","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2023.05.001_bib53","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1167\/iovs.15-18595","article-title":"The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta-analysis","volume":"57","author":"McCann","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2023.05.001_bib54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaophthalmol.2019.0900","article-title":"Association of statin use and high serum cholesterol levels with risk of primary open-angle glaucoma","volume":"137","author":"Kang","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2023.05.001_bib55","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ophtha.2012.04.029","article-title":"The relationship between statin use and open-angle glaucoma","volume":"119","author":"Stein","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2023.05.001_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029724","article-title":"Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study","volume":"7","author":"Marcus","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ophtha.2023.05.001_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jamaophthalmol.2016.5406","article-title":"Association of daily dosage and type of statin agent with risk of open-angle glaucoma","volume":"135","author":"Talwar","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2023.05.001_bib58","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaophthalmol.2015.1440","article-title":"Association of geroprotective effects of metformin and risk of open-angle glaucoma in persons with diabetes mellitus","volume":"133","author":"Lin","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2023.05.001_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamaophthalmol.2022.1435","article-title":"Association of diabetes medication with open-angle glaucoma, age-related macular degeneration, and cataract in the Rotterdam Study","volume":"140","author":"Vergroesen","year":"2022","journal-title":"JAMA Ophthalmology"},{"issue":"11","key":"10.1016\/j.ophtha.2023.05.001_bib60","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4103\/ijo.IJO_1486_21","article-title":"Association of metformin use among diabetics and the incidence of primary open-angle glaucoma\u2014the Chennai Eye Disease Incidence Study","volume":"69","author":"George","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.05.001_bib61","series-title":"Therapy in Nephrology & Hypertension","first-page":"610","article-title":"Calcium channel blockers","author":"Shemin","year":"2008"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023003068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023003068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:13:15Z","timestamp":1758982395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023003068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0161642023003068"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.05.001","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Systemic Medication Use with Glaucoma and Intraocular Pressure","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}